pioneer trials semaglutide Efficacy and safety of oral vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: 12, a double-blind, Phase IIIa, randomised trial | Diabetologia oral semaglutide trials Efficacy of

SURMOUNT-1 Trial Tirzepatide Once Weekly for the Treatment of Obesity (NEJM, 2022) 4

Head-to-head clinical data from the SURMOUNT-5 trial shows tirzepatide (Mounjaro) achieves greater weight loss

it's not the norm, but it's also not exceptionally rare

Think of it as less goes in, less comes out. Fewer bowel movements can be normal ( even as few as three per week ), but experiencing hard stool, difficulty passing stool, bloating, abdominal pain, or incomplete evacuation would be considered constipation

the usable window is whatever the compounding pharmacy can justify based on testing and quality controls, and refrigeration only slows chemical and microbial degradation